Mirvie is dedicated to shaping the future of pregnancy health
Mirvie is shaping the future of pregnancy health by providing women and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.
The Future of Pregnancy Health Starts Here
One in five pregnancies is impacted by complications.
The Mirvie RNA platform has the power to predict them before they happen123 enabling proactive, preventive, and personalized pregnancy care for the well-being of millions of moms and babies.
The idea for Mirvie was sparked by the personal experience of one of the founders whose daughter was born prematurely.
Mirvie’s world-class team of scientists and entrepreneurs.
Mirvie’s team members have brought to market category-first, non-invasive tests in both women’s health and in early cancer detection, used by millions today.
Alison Cowan, M.D.
Head of Medical Affairs
Michal Elovitz, M.D.
Chief Medical Advisor
Head of Software Engineering
Head of Product Management
Chief Executive Officer
Vice President of Finance
Chief Operating Officer
Head of Clinical Operations
Senior Vice President of Research & Development
Scientific Advisory Board Chair & Co-Founder
Head of Research
Mirvie has raised more than $90 million in early-stage financing from top-tier investors.
Interested in helping us shape the future of pregnancy health?
We want to hear from you!